Post A Reply
my profile
login
|
register
|
search
|
faq
|
forum home
»
Allstocks.com's Bulletin Board
»
Micro Penny Stocks, Penny Stocks $0.10 & Under
»
GVBP HUGE NEWS
» Post A Reply
Post A Reply
Login Name:
Password:
Message Icon:
Message:
HTML is not enabled.
UBB Code™ is enabled.
[QUOTE]Originally posted by Hot-Pepper: [QB] Skymark Research Initiates Independent Research Coverage On Genova Biotherapeutics, Inc. Sep 15, 2009 09:25:54 (ET) CALGARY, Alberta, Sep 15, 2009 (GlobeNewswire via COMTEX) -- Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on Genova Biotherapeutics, Inc. (GVBP, Trade ). Skymark Research is currently offering a complimentary trial subscription. To view our research go to: [URL=http://www.skymarkresearch.com]www.skymarkresearch.com[/URL] About SMR: Skymark Research is a leading provider of independent investment research in North America. Our services include research analysis on the small- and micro-cap markets, real-time news and financial data, market commentary and the SMR newsletter. Skymark Research's staff of small-cap investment professionals is dedicated to providing the small market's investment community with the tools and avenues necessary to make the important investment decisions. To view our research reports on a complimentary trial basis and take advantage of our other services, go to [URL=http://www.skymarkresearch.com]www.skymarkresearch.com[/URL] and click on the complimentary trial subscription button on our home page, or go directly to our registration page at [URL=http://www.skymarkresearch.com/signup.php]www.skymarkresearch.com/signup.php[/URL] . About Genova Biotherapeutics, Inc. (GVBP, Trade ): Genova Biotherapeutics, Inc (GVBP, Trade ) is positioning itself as the world's leading bioscience company in the development and commercial licensing of novel therapeutic proteins that disrupt the advance of life-threatening cancers. The company leverages cutting-edge research collaborations to achieve breakthroughs in anti-cancer treatments, and then licenses these patented drug product candidates to Big Pharmaceutical and Biotechnology companies such as Pfizer, Amgen, Myriad Genetics, Medarex, and Biogen Idec. Visit Genova online at [URL=http://www.genovabio.com]www.genovabio.com[/URL] . SMR Disclosure: Skymarkresearch.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Skymark Research has not been compensated by any of the above mentioned companies. Please read our report and visit our Web site, [URL=http://www.skymarkresearch.com]www.skymarkresearch.com[/URL] , for complete risks and disclosures. This news release was distributed by GlobeNewswire, [URL=http://www.globenewswire.com]www.globenewswire.com[/URL] SOURCE: Skymark Research CONTACT: Skymark Research Dylan Boyle 202-657-6249 info*skymarkresearch.com [/QB][/QUOTE]
Instant Graemlins
Instant UBB Code™
What is UBB Code™?
Options
Disable Graemlins in this post.
*** Click here to review this topic. ***
Contact Us
|
Allstocks.com Message Board Home
© 1997 - 2021 Allstocks.com. All rights reserved.
Powered by
Infopop Corporation
UBB.classic™ 6.7.2